Inhibikase Therapeutics shares owned by Integral Health Asset Management
Quarter-by-quarter ownership of Inhibikase Therapeutics (IKT) shares owned by Integral Health Asset Management
from 13F filings
Historical chart of Integral Health Asset Management investment in Inhibikase Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Inhibikase Therapeutics held by Integral Health Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Inhibikase Therapeutics by Integral Health Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-06-30 | $2.7M | 1.4M | 2.03 |
| 2026-03-31 | $2.3M | 1.4M | 1.68 |
| 2025-12-31 | $3.6M | 1.8M | 2.05 |
More positions owned by Integral Health Asset Management
View all positions for Integral Health Asset Management